06.05.2024 - Press release, Helsinki, 6 May 2024 at 9 AM (EEST) Health Canada Approves Nexstim NBS 6 System for Treatment of MDD Nexstim Plc (NXTMH:HEX) ( Nexstim or Company ) has received approval from Health Canada for the marketing and commercial .
Conference Call and Webcast at 8:30AM Eastern Time
NEW YORK, May 2, 2024 /PRNewswire/ Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company and.
Nexstim Plc Resolved on a New Stock Option Plan 2024H streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.